Clinerion Expands Team and Moves to New Headquarters in Basel
Clinerion's move to new headquarters is driven by growth in its business and its team, and matches the expansion in its international network of partner hospitals.
BASEL, Switzerland, Nov. 05, 2018 /PRNewswire-PRWeb/ -- Clinerion is moving to new offices in Basel, Switzerland. Following strong expansion in its business, the company is in the process of growing its global team. In the six months leading up to the start of 2019, the company expects to have added several additional new positions. Staffing is increasing in all areas of the company, from Customer Solutions to Site & Patient Network Development, from Software Development to Data Analytics and Marketing.
Clinerion's new offices have nearly double the floorspace of its old premises, matching the increased requirements of its expanding business. The company's headquarters remain in Basel, Switzerland, the major worldwide hub for the pharmaceutical industry, and global headquarters of two of the world's top ten pharma companies. From here, Clinerion's analysts will tap into and derive valuable insights from anonymized patient data throughout its network of hospital and data partners.
"Basel has critical mass in its life sciences ecosystem and an infrastructure which promotes a strong innovation culture," says Ian Rentsch, Clinerion CEO. "Here, we have the opportunity to interact with leaders of the industry on a close, daily basis. We are happy to be here!"
"This move offers our employees an improved working environment to support clients and partners more effectively and efficiently, with space for radical, disruptive ideas, and it is in addition a proof of the Board's trust in the future growth potential," says Pierre Jaccoud, Chairman of the Board of Clinerion.
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion's proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: http://www.clinerion.com
Clinerion's Patient Network Explorer: http://www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
[email protected]
SOURCE Clinerion
Share this article